Corvus Pharmaceuticals, Inc. — Director's Dealing 2018

Mar 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2018-03-12

Reporting Person: MILLER RICHARD A MD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-12	Common Stock, $0.0001 par value	P	100000	$8.50	Acquired	1112293	Indirect

Footnotes

F1: Reporting Person purchased 100,000 shares of Issuer's common stock in connection with a public offering at the offering price of $8.50 per share.

F2: A portion of these shares is subject to a right of repurchase held by the Issuer.

F3: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.